pcFLAG-Grap2-WT
(Plasmid
#74511)
-
PurposeOverexpression of Grap2 in mammalian cells
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 74511 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcFLAG
-
Backbone manufacturerthis lab, modified from pcDNA3
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameGrap2
-
SpeciesH. sapiens (human)
-
Entrez GeneGRAP2 (a.k.a. GADS, GRAP-2, GRB2L, GRBLG, GRID, GRPL, GrbX, Grf40, Mona, P38)
- Promoter CMV
-
Tag
/ Fusion Protein
- FLAG (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site unknown (unknown if destroyed)
- 3′ cloning site unknown (unknown if destroyed)
- 5′ sequencing primer CMV-F
- 3′ sequencing primer BGHrev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The depositor notes that a BamHI restriction site was inserted following the start codon of Grap2. This site does not affect plasmid function.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcFLAG-Grap2-WT was a gift from Lars Rönnstrand (Addgene plasmid # 74511 ; http://n2t.net/addgene:74511 ; RRID:Addgene_74511) -
For your References section:
Expression of GADS enhances FLT3-induced mitogenic signaling. Chougule RA, Cordero E, Moharram SA, Pietras K, Ronnstrand L, Kazi JU. Oncotarget. 2016 Feb 15. doi: 10.18632/oncotarget.7415. 10.18632/oncotarget.7415 PubMed 26895103